Jason Heikenfeld,
Professor and VP Operations, UC Office of Innovation,
University of Cincinnati
Jason Heikenfeld is VP of Operations at the Univ. of Cincinnati Office of Innovation. He also directs the Novel Devices Laboratory, an internationally leading lab in electronic display technology, microfluidics, electronic paper, and most recently minimally invasive biosensing technology. In the first decade of his career, Jason Heikenfeld is VP of Operations at the Univ. of Cincinnati Office of Innovation. He also directs the Novel Devices Laboratory, an internationally leading lab in electronic display technology, microfluidics, electronic paper, and most recently minimally invasive biosensing technology. In the first decade of his career, Dr. Heikenfeld had already accumulated the most patents and licensees of any faculty member in the history of the Univ. of Cincinnati. He is a serial entrepreneur, and one of his recent startups, Eccrine Systems, has been recognized as a top 50 global startup by Bloomberg. In addition to his scholarly work, during his teaching years Prof. Heikenfeld was the highest-rated STEM educator at the University of Cincinnati.
Wearable Eccrine Sweat Biosensing: Uncovering The Real Challenges That Lie Ahead
Monday, 26 September 2016 at 18:00
Add to Calendar ▼2016-09-26 18:00:002016-09-26 19:00:00Europe/LondonWearable Eccrine Sweat Biosensing: Uncovering The Real Challenges That Lie AheadNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Despite the many ergonomic advantages of eccrine perspiration (sweat) compared to other biofluids (particularly in “wearable” devices), sweat remains an underrepresented source of biomarker analytes compared to the established biofluids blood, urine, and saliva. Upon closer comparison to other non-invasive biofluids, the advantages may even extend beyond ergonomics: sweat might provide superior analyte information. A number of challenges, however, have historically kept sweat from its place in the pantheon of clinical samples. These challenges include very low sample volumes (nL to µL), unknown concentration due to evaporation, filtration and dilution of large analytes, mixing of old and new sweat, and the potential for contamination from the skin surface. More recently, rapid progress in “wearable” sweat sampling and sensing devices has resolved several of the historical challenges. However, this recent progress has also been limited to high concentration analytes (µM to mM) sampled at high sweat rates (>1 nL/min/gland, e.g. athletics). Progress will be much more challenging as sweat biosensing moves towards use with sedentary users (low sweat rates or not sweating at all) and/or towards low concentration analytes (pM to nM). Fortunately, none of the remaining challenges appear to be fundamentally blocking, and scientific and engineering innovations have the opportunity to enable broader application of sweat biosensing technology.
Add to Calendar ▼2016-09-26 00:00:002016-09-28 00:00:00Europe/LondonNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016NGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2016-09-26 18:00:002016-09-26 19:00:00Europe/LondonWearable Eccrine Sweat Biosensing: Uncovering The Real Challenges That Lie AheadNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
